Not applicableLooking for participantsNCT04892849
What this trial is testing
Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and Radiotherapy
Who this might be right for
HNSCCNSCLCEsophageal Cancer+4 more
University of Erlangen-Nürnberg Medical School 200